Does Health Net Cover Cialis (Tadalafil)? A Complete 2025 Coverage Guide

How the FDA-Approved Indications for Tadalafil Affect Coverage

Tadalafil's approved indication determines which benefit category a health plan uses to adjudicate the claim. The FDA has approved tadalafil for three distinct conditions: erectile dysfunction (ED) under the brand Cialis, benign prostatic hyperplasia (BPH) under Cialis, and pulmonary arterial hypertension (PAH) under the brand Adcirca. [1] Each carries a different ICD-10 code and often a different formulary status.

The FDA first approved tadalafil for ED in 2003 and for BPH in 2011. [1] Generic tadalafil tablets entered the U.S. market in 2018 after the core Eli Lilly patent expired, driving the average wholesale price from roughly $400 for a 30-count to under $30 for many 90-count supplies at retail pharmacies. [2]

ED affects an estimated 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases. [3] BPH affects roughly 50% of men in their 50s and up to 90% of men in their 80s. [4] Because BPH is classified as a medical condition rather than a lifestyle concern, insurers including Health Net treat the BPH indication with fewer coverage restrictions than the ED indication, which many commercial plans categorize as elective. This classification distinction is the single most consequential factor when asking whether Health Net will pay for your prescription.

A 2022 analysis published in JAMA Internal Medicine found that coverage of ED medications by commercial insurers remained inconsistent, with fewer than 25% of large employer plans covering phosphodiesterase type 5 (PDE5) inhibitors for ED without significant cost-sharing barriers. [5] Tadalafil's dual ED and BPH labeling means your prescriber's choice of diagnosis code can legally affect whether the claim clears.

Health Net Formulary Tiers: Where Tadalafil Usually Lands

Health Net organizes drugs into five tiers. Tier 1 is preferred generics; Tier 2 is non-preferred generics; Tier 3 is preferred brand; Tier 4 is non-preferred brand; Tier 5 is specialty. Brand Cialis, when it appears at all, typically sits at Tier 4 or is excluded entirely on Health Net Exchange (Covered California) and commercial group plans. Generic tadalafil is most commonly placed at Tier 2, with a copay of $20, $50 depending on your deductible status.

Health Net's publicly posted 2024 commercial formularies list tadalafil 5 mg, 10 mg, and 20 mg as covered with prior authorization on its Salud HMO and Health Net of California PPO products. [6] The 2.5 mg dose (used for once-daily BPH therapy) also appears as a covered entry under most formularies when coded to N40.1 (BPH with lower urinary tract symptoms). Prescriptions coded solely to N52 (male erectile dysfunction) face a higher denial rate without additional documentation.

The PDE5 inhibitor class as a whole has been the subject of ongoing formulary restriction debate. The American Urological Association (AUA) 2021 guideline on ED states: "Phosphodiesterase type 5 inhibitors are the recommended first-line pharmacotherapy for erectile dysfunction in appropriately selected patients." [7] Insurers that exclude PDE5 inhibitors are therefore placing cost barriers in front of a guideline-endorsed first-line treatment.

Checking your specific plan's formulary at healthnet.com or calling the member services number on your insurance card before filling a prescription is the fastest way to confirm your tier and copay amount.

Prior Authorization Requirements for Health Net Tadalafil Coverage

Prior authorization (PA) is required for tadalafil on most Health Net commercial plans. The PA process asks a prescribing clinician to document clinical necessity. Approval timelines run 24 to 72 hours for standard requests and 8 hours for urgent requests under California Department of Managed Health Care rules. [8]

Health Net's PA criteria for tadalafil generally include the following elements. First, the prescriber must confirm a clinical diagnosis supported by objective findings (AUA symptom score for BPH, or documented history and physical for ED). Second, the prescriber must note any contraindications to nitrate co-administration, given that concomitant use of tadalafil and organic nitrates is an absolute contraindication due to severe hypotensive risk. [9] Third, for BPH, some Health Net plan documents require documentation that alpha-blocker monotherapy (typically tamsulosin 0.4 mg) was trialed for at least 4 to 6 weeks before tadalafil is added or substituted. [10]

A 2023 JAMA Network Open study found that prior authorization requirements for ED medications were associated with a 34% reduction in prescription fills among eligible men, raising concerns about access equity. [11] If Health Net denies your PA, you have the right to an independent medical review through the California Department of Managed Health Care within 30 days of denial. [8]

Preparing a complete PA submission from the start reduces delays. Your clinician should include: the relevant ICD-10 code, baseline symptom scores (International Index of Erectile Function or AUA-SI), any prior treatment attempts, and documentation ruling out nitrate use and contraindications.

Tadalafil for BPH: A Stronger Coverage Case

When tadalafil is prescribed for BPH (N40.1), the clinical and insurance case is considerably more straightforward than for ED alone. The AUA's 2022 guideline on surgical and medical management of BPH endorses tadalafil 5 mg once daily as an evidence-based option for men with lower urinary tract symptoms (LUTS) secondary to BPH, particularly when ED coexists. [10]

The key clinical evidence: a 12-week randomized controlled trial published in the Journal of Urology (N=325) found tadalafil 5 mg once daily significantly improved International Prostate Symptom Score (IPSS) by a mean of 5.6 points versus 3.6 points for placebo (P<0.001). [12] A separate 2018 meta-analysis in European Urology (17 RCTs, N=3,398) confirmed that tadalafil 5 mg reduced IPSS by 5.5 points and IIEF score improved by 6.1 points versus placebo. [13]

Health Net Medi-Cal managed care plans, which cover low-income Californians, list tadalafil 5 mg on the Medi-Cal formulary for BPH. The California Department of Health Care Services Medi-Cal formulary does not routinely cover tadalafil for ED as a standalone indication without medical exception requests. [14] Filing a treatment authorization request (TAR) with supporting AUA-SI documentation can succeed, though approval rates are lower than for the BPH pathway.

The clinical overlap between BPH and ED is high. Studies show 44 to 63% of men with BPH also have co-occurring ED. [13] A single prescription of tadalafil 5 mg once daily can address both conditions simultaneously under dual-diagnosis coding (N40.1 and N52.9), which may improve the insurance coverage outcome compared with coding for either condition alone.

What Health Net Covers vs. Excludes: Brand vs. Generic

The practical rule for 2025: generic tadalafil yes, brand Cialis probably not without a fight.

Brand Cialis (Eli Lilly) carries a list price near $430 for 30 tablets of 20 mg as of early 2025. Health Net's non-preferred brand tier (Tier 4) typically requires 40 to 50% coinsurance after the deductible, making brand Cialis cost $170, $215 per fill even with coverage. Most Health Net plan documents include an "exclusions" schedule listing brand-name drugs that have a generic equivalent; Cialis is commonly on this list, meaning the plan pays zero for brand and full cost falls to the patient. [6]

Generic tadalafil from major manufacturers including Teva, Sun Pharma, Amneal, and others is bioequivalent to brand Cialis. The FDA requires generics to demonstrate bioequivalence within a ±20% confidence interval for AUC and Cmax relative to the reference product. [15] Clinical performance is therefore expected to be the same as brand. The AUA does not distinguish between brand and generic tadalafil in its clinical recommendations.

For patients on a Health Net plan that excludes brand Cialis, requesting that the prescriber write the prescription as "tadalafil" (generic) rather than "Cialis" bypasses the brand exclusion entirely. This is the simplest cost-reduction step available.

Cost Without Coverage and Discount Options

Even without Health Net coverage, the out-of-pocket cost for generic tadalafil has dropped substantially since 2018. Cash prices as of January 2025 through major discount programs:

GoodRx lists generic tadalafil 5 mg (30 tablets) at $14, $28 at CVS, Walgreens, and Costco with a free GoodRx coupon. [16] Mark Cuban's Cost Plus Drugs (costplusdrugs.com) offers tadalafil 5 mg (90 tablets) for approximately $21.60 plus dispensing fee. Eli Lilly's Cialis savings card for commercially insured patients can reduce brand copays to $30, $50 per fill, though it cannot be combined with federal insurance programs (Medicare, Medicaid, TRICARE). [17]

Medicare Part D coverage of tadalafil for ED remains explicitly excluded under the Social Security Act Section 1927(d)(2)(B), which prohibits Part D plans from covering drugs used for sexual or erectile dysfunction unless medically necessary for a non-ED condition such as BPH or PAH. [18] This federal exclusion does not apply to Health Net commercial plans, though those plans set their own formulary rules.

The Veterans Health Administration (VHA) covers tadalafil for service-connected ED, which is a model cited in health policy discussions about broadening commercial coverage. [19]

How to Get Health Net to Approve Tadalafil: Step-by-Step

Getting approval follows a predictable path when documentation is organized correctly.

Step one: confirm the diagnosis. Your provider should document either BPH with LUTS (AUA-SI score of 8 or above) or ED with history and physical findings, or both. The AUA-SI is a validated 7-question tool whose score directly supports medical necessity. [7]

Step two: rule out nitrate use. Tadalafil is absolutely contraindicated with nitrates. [9] Documenting that no nitrates are prescribed eliminates a common PA rejection reason.

Step three: submit the PA with supporting clinical notes. The PA form should reference the AUA 2021 ED guideline [7] and AUA 2022 BPH guideline [10] directly, stating the patient meets criteria for first-line PDE5 inhibitor therapy.

Step four: if denied, request a peer-to-peer review. A treating physician speaking directly to Health Net's medical reviewer resolves many denials that automated systems flag. A 2020 study in Health Affairs found that peer-to-peer review overturned prior authorization denials at a rate of approximately 75% in outpatient specialty settings. [20]

Step five: file an appeal. California law requires Health Net to complete a standard appeal within 30 days and an expedited appeal within 72 hours. [8] The California Department of Managed Health Care's Independent Medical Review program resolves disputes where Health Net's internal appeal fails.

Tadalafil Dosing Relevant to Coverage Decisions

Health Net formularies typically list specific doses, so the right dose on the prescription matters for the PA outcome. The FDA-approved tadalafil dosing schedule has two formats. [1]

For on-demand ED use: 10 mg taken at least 30 minutes before sexual activity, with a maximum of 20 mg per dose and no more than one dose per 24 hours. For once-daily ED use: 2.5 mg starting dose, titrated to 5 mg. For BPH (with or without ED): 5 mg once daily. For PAH (Adcirca): 40 mg once daily as a separate brand formulation.

Renal and hepatic dose adjustments apply. In patients with creatinine clearance 30 to 50 mL/min, the maximum on-demand dose is 5 mg. In patients with creatinine clearance below 30 mL/min, tadalafil is not recommended. [1] Health Net PA reviewers may request renal function documentation before approving higher doses.

A 2019 review in the New England Journal of Medicine noted that tadalafil's 17.5-hour half-life supports once-daily dosing and is responsible for the drug's reputation as the "weekend pill" given its 36-hour window of efficacy. [21] This pharmacokinetic profile distinguishes tadalafil from sildenafil (Viagra, half-life 3 to 5 hours) and vardenafil (Levitra, half-life 4 to 5 hours).

Health Net Plan Types and How They Differ on Tadalafil

Health Net operates HMO, PPO, EPO, and Medi-Cal managed care products. Formulary rules differ across these.

Health Net of California HMO plans follow a closed formulary. Drugs not on the formulary are not covered without a medical exception. Generic tadalafil appears on most HMO formularies at Tier 2 with PA required. Health Net PPO plans use an open formulary structure where non-formulary drugs can be covered at higher cost-sharing; tadalafil on an HMO may require a $40 copay where the same drug on a PPO costs $25 after PA approval.

Health Net's Covered California (Exchange) plans must comply with the ACA's essential health benefits framework, though ED medications are not in any of the ten EHB categories. The California Department of Insurance has not mandated ED drug coverage as an EHB, so Exchange plans retain discretion to exclude it. [22] BPH treatment does fall within the medical and surgical EHB category, giving tadalafil for BPH a stronger coverage footing on Exchange plans.

Health Net Medicare Advantage plans are governed by CMS formulary rules. CMS excludes ED drugs from Medicare Part D coverage per federal statute [18], and Health Net's MA-PD products follow the same restriction. Patients on Health Net Medicare Advantage using tadalafil for ED pay out of pocket, though GoodRx coupons are usable since the purchase is cash-pay.

Drug Interactions and Safety Considerations That Affect Prescribing

Safe prescribing determines whether the prescription gets written at all, which precedes any insurance question.

Tadalafil's most serious interaction is with nitrates. Combined use with isosorbide mononitrate, nitroglycerin, or any organic nitrate is absolutely contraindicated due to a risk of severe hypotension that may be fatal. [9] The FDA label also cautions against concurrent use with alpha-blockers (including tamsulosin) due to additive hypotensive effects, though co-administration is acceptable at recommended doses with monitoring. [1]

CYP3A4 inhibitors such as ketoconazole, ritonavir, and clarithromycin increase tadalafil plasma concentration. Patients on ritonavir should not exceed 10 mg of tadalafil in a 72-hour period. [1] CYP3A4 inducers such as rifampin reduce tadalafil exposure and may reduce efficacy. [1]

Tadalafil is classified as FDA Pregnancy Category B based on animal studies, though it is not indicated for use in women outside of the PAH indication. [1] The drug is not approved for pediatric populations.

A 2021 pharmacovigilance review in Drug Safety analyzed adverse event reports for tadalafil and found that cardiovascular events were most commonly associated with undisclosed nitrate co-use, reinforcing contraindication screening as a patient safety priority. [23] Health Net PA criteria specifically screen for nitrate co-prescriptions in part because cardiovascular liability is a known risk.

When Tadalafil is Covered Under Health Net: A Practical Summary

Coverage is most likely when these four conditions are met simultaneously: the prescription is written for generic tadalafil (not brand Cialis), the diagnosis code includes BPH with LUTS (N40.1), the prescriber submits a complete prior authorization with AUA guideline references and documented nitrate exclusion, and the patient has a commercial Health Net plan rather than a Medicare Advantage or Medi-Cal plan restricted to BPH.

Coverage is least likely when the prescription is brand Cialis coded to ED-only (N52), submitted without a PA, on a Medicare Advantage or highly restrictive Medi-Cal plan.

The Endocrine Society's 2019 Clinical Practice Guideline on Male Hypogonadism notes that sexual function, including erectile function, has direct effects on quality of life and psychological wellbeing, and that barriers to treatment represent a measurable health burden. [24] Insurance coverage gaps for PDE5 inhibitors therefore carry real clinical consequences beyond inconvenience.